Sensei Biotherapeutics
SNSE
SNSE
26 hedge funds and large institutions have $4.71M invested in Sensei Biotherapeutics in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
–
Holders Change %
0%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
NM
Newtyn Management
New York
|
+$578K |
| 2 |
Morgan Stanley
New York
|
+$193K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$136K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$62K |
| 5 |
Millennium Management
New York
|
+$4.43K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$71.1K |
| 2 |
WSL
Western Standard LLC
Los Angeles,
California
|
-$68.7K |
| 3 |
VF
Virtu Financial
New York
|
-$39K |
| 4 |
E
Ergoteles
New York
|
-$28.2K |
| 5 |
Two Sigma Investments
New York
|
-$23.7K |
